Common questions about Caflam (FAQ)
Q: What is Caflam mainly prescribed for?
Official prescribing information indicates that Caflam (diclofenac potassium) is used for the relief of mild to moderate pain, including the treatment of primary dysmenorrhea (menstrual pain). It is also prescribed to relieve the signs and symptoms of certain chronic inflammatory conditions, such as osteoarthritis and rheumatoid arthritis.
Q: Is Caflam the same as Voltaren?
Both Caflam and Voltaren are brand names for the active compound diclofenac, but they use different salt forms. Caflam contains diclofenac potassium, while Voltaren often contains diclofenac sodium. This difference in salt form affects how quickly the drug is absorbed by the body.
Q: Why does Caflam have a different name in some countries?
It is common for official prescribing information to note that certain specific products or brand names may not be available across all countries due to different regulatory approvals and marketing decisions. Therefore, a drug with the same active ingredient may be known by various names globally.
Q: What is the difference between Caflam and paracetamol?
Official drug labeling classifies Caflam as a Nonsteroidal Anti-inflammatory Drug (NSAID), meaning it works by reducing the production of inflammatory chemical signals (prostaglandins). Paracetamol (acetaminophen), while also used for pain and fever, is classified as a different type of analgesic and does not share the same anti-inflammatory mechanism as NSAIDs.
Q: How quickly should Caflam start working for pain?
Pharmacokinetic data from studies on diclofenac immediate-release formulations suggest that the onset of action is generally described as being within 30 minutes after taking the tablet. This information refers to group averages observed in trials.
Q: How long does the effect of one dose of Caflam last?
Official pharmacokinetic information reports that the elimination half-life for unchanged diclofenac is approximately 1.2 to 2 hours. The half-life is a measure of how long it takes for half of the medicine to be cleared from the body.
Q: Are there any signs that Caflam might be affecting my liver?
Official labeling advises that patients should be informed about potential signs and symptoms of liver toxicity, such as fatigue, nausea, or jaundice. The product information states that discontinuation is advised if liver tests worsen or if clinical signs of liver disease develop.
Q: Is it common to feel drowsy after taking Caflam?
Official prescribing information lists both 'drowsiness' and 'somnolence' among the potential adverse reactions that affect the nervous system. These are documented side effects, alongside other nervous system disorders like headache and dizziness.
Q: Can Caflam be taken with other common over-the-counter pain relievers?
Official safety guidance advises against combining Caflam with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as aspirin or ibuprofen. However, safety information generally indicates that it is acceptable to take diclofenac with non-NSAID pain relievers like paracetamol or codeine.
Q: Can I use Caflam if I have high blood pressure?
The official product information lists patients with uncontrolled hypertension as a population that requires caution when using this drug. Furthermore, diclofenac may diminish the effects of certain blood pressure medications, which is a key interaction point.
Q: Is Caflam safe for people with asthma?
Official labeling states that the drug is strictly contraindicated (must not be used) in patients with aspirin-sensitive asthma. Official labeling also includes an advisory that caution should be used in all patients with pre-existing asthma.
Q: Is it possible to become dependent on Caflam?
Official drug labeling notes that Caflam is not listed on any DEA Schedule. This classification indicates that the regulatory authority does not classify the medication as having a high potential for abuse or dependency.
Q: Does Caflam affect sleep or cause insomnia?
Official prescribing information lists 'insomnia' (difficulty sleeping) and 'dream abnormalities' among the potential adverse reactions that affect the nervous system. These are documented effects that may occur in some patients.
Q: What should I do if I miss a dose of Caflam?
Patient information generally advises that if a dose is missed, and it is almost time for the next scheduled dose, the regulatory instruction is to skip the missed dose. It is recommended that a double dose should not be taken to catch up.
Q: Is there a generic version of Caflam available?
The active ingredient in Caflam, diclofenac potassium, has been reviewed by regulatory bodies like the FDA, and there are approved generic versions of this formulation available on the market.
Q: Are there any dietary restrictions when using Caflam?
Official prescribing information highlights that alcohol use is listed as a factor that may increase the risk for serious gastrointestinal bleeding. No specific food-based dietary restrictions are typically noted beyond the recommendation regarding alcohol.
Q: Is Caflam a drug that requires a prescription?
Official drug labeling classifies this formulation (diclofenac potassium immediate-release tablets) as a Human Prescription Drug. This means that a valid prescription from a licensed healthcare provider is required to obtain the medication.
Q: What does 'contraindicated' mean in the context of Caflam use?
The term 'contraindicated' is used in drug labeling to define a condition or factor that serves as a documented reason to withhold a specific medical treatment. In the case of Caflam, it signifies that the documented risk of harm outweighs the benefit for that population or condition.
Q: What are the official recommendations for stopping the use of Caflam?
Official warnings state that immediate discontinuation of the drug is required if a serious gastrointestinal adverse event, such as ulceration or bleeding, is suspected. Regulatory guidance also emphasizes the general principle of using the lowest effective dose for the shortest possible duration.
Q: Does Caflam interact with herbal supplements?
Official safety information advises that complementary medicines, herbal remedies, and supplements are generally not tested in the same way as prescription medicines for their potential to cause drug interactions. Therefore, potential interactions with such products may not be fully known.
Q: What is the difference between Caflam and other NSAIDs?
Caflam's formulation uses the potassium salt of diclofenac, which is designed to be an immediate-release salt for faster absorption. This formulation difference is key to distinguishing it from other diclofenac salts and some other NSAIDs.
Q: What is the evidence level supporting Caflam’s use for its main indications?
Regulatory reviews describe the evidence base as being consistent with an increased risk of serious cardiovascular events, but also note that the overall risk-benefit profile is maintained for the approved uses. This profile is the basis for its continued regulatory approval.
Q: Is the active ingredient in Caflam widely studied?
The active ingredient, diclofenac, is a well-established Nonsteroidal Anti-inflammatory Drug (NSAID). Various formulations have been the subject of extensive regulatory review and study, with approvals granted by the FDA and other bodies dating back several decades.
Q: What is the meaning of the dosage strength of Caflam tablets?
The dosage strength listed on the tablet, such as 50 mg, refers to the precise amount of the active ingredient, diclofenac potassium, that is contained within a single tablet dosage unit. This is the weight of the medicine intended to exert the therapeutic effect.
